Roivant Sciences ROIV Cash Flow Statement
| TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | TTM Q4 '24 | ||
|---|---|---|---|---|---|---|
| —— | -$955.47M-1,336% | -$523.69M-111% | -$637.58M-113% | -$318.93M-107% | ||
| $3.35M-76.2% | $4.14M-76.9% | $6.37M-68.7% | $10.29M-51.2% | $14.07M-36.1% | ||
| $346.17M+19.8% | $352.48M+39.7% | $331.17M+48.6% | $321.02M+60.1% | $289.03M+44.8% | ||
| -$750.35M+10.6% | -$759.1M+2.1% | -$769.86M+1.1% | -$851.01M-20.2% | -$839.45M-9.7% | ||
| —— | —— | $14.52M+445% | $7.67M+294% | $4.6M+233% | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | $853.14M+31.6% | $1.29B— | ||
| —— | —— | —— | -$746.95M-246% | -$1.22B-370% | ||
| —— | —— | —— | —— | —— | ||
| -$758.56M+10.1% | -$766.86M+1.6% | -$784.38M-0.4% | -$858.67M-20.9% | -$844.05M-10.1% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Roivant Sciences generate?
- Roivant Sciences (ROIV) generated -$750.3M in operating cash flow over the trailing twelve months.
- What is Roivant Sciences's free cash flow?
- After $14.0M of capital expenditures, Roivant Sciences's free cash flow was -$758.6M over the trailing twelve months, up 10.1% year over year.
- Where does Roivant Sciences's cash flow data come from?
- Every line is extracted from Roivant Sciences's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
